|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization | |||||
| Gain on divestiture of business, excluding transaction costs (Note 4) | |||||
| Deferred income tax provision/(benefit) (Note 10) | |||||
| Other non-cash items, net | |||||
| Increase/(decrease) in cash, excluding the effects of acquisitions and divestitures, resulting from changes in: | |||||
| Other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Income taxes payable (Note 10) | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Payments for capitalized contract costs | |||||
| Payments for internal use software | |||||
| Purchases of property and equipment | |||||
| Purchases of settlement investments | |||||
| Settlement Investments | |||||
| Proceeds from the sale of settlement investments | |||||
| Settlement Investments | |||||
| Non Settlement Investment | |||||
| Maturities of settlement investments | |||||
| Settlement Investments | |||||
| Other investing activities | |||||
| Net cash provided by/(used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Cash dividends and dividend equivalents paid (Note 12) | |||||
| Common stock repurchased (Note 12) | |||||
| Net proceeds from/(repayments of) commercial paper | |||||
| Net proceeds from credit facility borrowings | |||||
| Net proceeds from issuance of borrowings | |||||
| Principal payments on borrowings | |||||
| Proceeds from exercise of options | |||||
| Net change in settlement obligations | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Net change in cash and cash equivalents, including settlement, and restricted cash | |||||
| Cash and cash equivalents, including settlement, and restricted cash at beginning of period | |||||
| Cash and cash equivalents, including settlement, and restricted cash at end of period | |||||
| Supplemental cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Cash paid for lease liabilities | |||||
| Non-cash lease liabilities arising from obtaining right-of-use assets (Note 11) | |||||
| Reconciliation of balance sheet cash and cash equivalents to cash flows: | |||||
| Cash and cash equivalents on balance sheet | |||||
| Settlement cash and cash equivalents (Note 7) | |||||
| Restricted cash in Other assets | |||||
| Cash and cash equivalents included in Assets held for sale (Note 4) | |||||
Loading...